April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Evaluation of Race as a Risk Factor for Retinopathy of Prematurity
Author Affiliations & Notes
  • Stephen Tse
    Ophthalmology, Loma Linda University, Loma Linda, CA
  • Blen Eshete
    Ophthalmology, Loma Linda University, Loma Linda, CA
  • Howard Kao
    Ophthalmology, Loma Linda University, Loma Linda, CA
  • Heather Chang
    Ophthalmology, Loma Linda University, Loma Linda, CA
  • Joseph Fan
    Ophthalmology, Loma Linda University, Loma Linda, CA
  • Footnotes
    Commercial Relationships Stephen Tse, None; Blen Eshete, None; Howard Kao, None; Heather Chang, None; Joseph Fan, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4480. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephen Tse, Blen Eshete, Howard Kao, Heather Chang, Joseph Fan; Evaluation of Race as a Risk Factor for Retinopathy of Prematurity. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4480.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To analyze various risk factors for the incidence and severity of retinopathy of prematurity (ROP) with particular attention to race.

 
Methods
 

Data was analyzed from 914 infants who received screening for ROP in the neonatal intensive care unit at Loma Linda University Children’s Hospital from 2001 to 2010. Excluded from this study were 250 patients due to incomplete follow-up (202) or death prior to reaching a disease endpoint (48). The data consisted of demographic characteristics, presence of major comorbidities, duration of oxygen supplementation, and incidence and severity of ROP. A multiple logistics regression model was used to determine the relation of these variables to the incidence (disease at any stage) and severity (stage 3-5 or high risk disease requiring intervention) of ROP.

 
Results
 

The incidence of ROP during the studied time period was 42.3% (387/914) for disease at any stage and 22.1% (202/914) for severe disease. Among infants who were diagnosed with ROP, 51.2% (198/387) experienced spontaneous resolution of their disease while 48.8% (189/387) required laser photocoagulation. There was no significant variation in ROP incidence due to sex (p = 0.91) or race (p = 0.18) when adjusting for other factors. White infants collectively had similar rates of disease compared to black infants (42.6% versus 41.8%, respectively). When considered separately, white Hispanic infants had higher rates of ROP (46.2%) compared to their non-Hispanic white counterparts (38.3%), although this disparity was insignificant. Disease severity and laser therapy rates were also similar across the racial groups. Birth weight, gestational age, and oxygen exposure were strongly linked to the development of ROP (p < 0.0001), but demonstrated non-linear relationships with regards to disease severity. A comparison of disease-free infants to ROP infants demonstrated a median birth weight of 1300 grams versus 815 grams, a median gestational age of 30 weeks versus 26 weeks, and a median supplemental oxygen duration of 20 days versus 94 days, respectively. ROP was associated with the presence of bronchopulmonary dysplasia (OR 7.99, 95% CI 5.86 - 10.88), patent ductus arteriosus (OR 3.48, 95% CI 2.62 - 4.61), necrotizing enterocolitis (OR 3.13, 95% CI 2.23 - 4.39), and sepsis (OR 2.29, 95% CI 1.75 - 3.00).

 
Conclusions
 

Contrary to the findings of the CRYO-ROP study, race is not an independent risk factor for the incidence or severity of ROP.

 
Keywords: 706 retinopathy of prematurity • 464 clinical (human) or epidemiologic studies: risk factor assessment • 463 clinical (human) or epidemiologic studies: prevalence/incidence  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×